ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Note

Decrease in rate of multiple sclerosis-related hospitalizations in Portugal

[version 1; peer review: 2 approved]
PUBLISHED 13 Jun 2016
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

We sought to investigate the rate of multiple sclerosis (MS)-related hospitalizations in Portugal and assess whether there have been temporal changes as described in other countries. Using data from the Portuguese National Discharge Registry, we observed that between 2008 and 2013 the rate of MS-related hospitalizations decreased by 44%, from 15.9/100 person-years (95% confidence interval (CI: 14.9-16.9) in 2008 to 8.9/100 person-years (95% CI: 8.2-9.6) in 2013. The change in hospitalization rates is in accordance with what has been observed in other countries, and coincides with the release of new therapies for MS in Portugal.

Keywords

multiple sclerosis, epidemiology, hospitalizations

Introduction

Multiple sclerosis (MS) is a chronic, neurodegenerative autoimmune disorder of the central nervous system1. With a prevalence of 1/800 in North America and Northern Europe, MS is the most common acquired neurological disorder in young adults1, posing a substantialburden on healthcare systems. Recent studies have, however, suggested that MS-related hospitalization rates have been declining over the last decades2,3.

Portugal is considered a region of medium MS prevalence4, but epidemiological data are limited. In the present study, we sought to investigate the difference in the rate of MS-related hospitalizations in Portugal between 2008 and 2013.

Methods

Data on the number of hospitalizations in 2008 and 2013 with an MS diagnosis [International Classification of Diseases, 9th revision (ICD 9): 340] were obtained from the National Hospital Discharge Registry, centrally held in the Portuguese Central Administration of the Health System. This database includes data about all hospitalizations in all public hospitals. In Portugal, the National Health Service provides universal access to healthcare and patients with MS are almost exclusively treated in public hospitals4. These years were chosen as MS prevalence data in 2008 and 2013 in Portugal were available from the Atlas of MS (http://www.msif.org/wp-content/uploads/2014/09/Atlas-of-MS.pdf)5. The total number of hospitalizations (1,177,048 in 2008 and 1,108,911 in 2013), as well as the estimates of the Portuguese population, were obtained from Portuguese official statistics6.

The incidence of hospitalizations (MS-related or all-cause hospitalizations) was calculated by dividing the number of hospitalizations in each year by the number of patients at risk in the same year. The Wald method was used to calculate 95% confidence intervals (CI). Two different definitions of MS-related hospitalizations were used: 1) where MS was the primary reason for admission — the MS ICD-9 diagnostic code was reported in the field of the primary diagnosis, and 2) where MS was reported as either a primary or a secondary reason for admission — the MS ICD 9 diagnostic code was in any position on the diagnoses fields (20 fields available). The proportion of MS-related hospitalizations in each year was obtained by dividing the number of MS-related hospitalizations in each year by the total number of hospitalizations in the same year. Demographic and clinical characteristics of patients with MS hospitalized in each year were described using number and percentage of patients for categorical variables, and mean and standard deviation (variables with a normal distribution) or median and interquartile range (variables with a skewed distribution) for continuous variables. Differences between characteristics in 2008 and 2013 were estimated using t-tests (variables with a normal distribution) or Mann–Whitney test (variables with a skewed distribution) for continuous variables, and Chi square test for other categorical variables. P values < 0.05 were considered to be statistically significant. Statistical analysis was performed using STATA software version 13.

Results

Demographic and clinical characteristics of patients with MS hospitalized in 2008 and 2013 are summarized in Table 1. Between 2008 and 2013, the incidence rate of MS-related hospitalizations decreased from 15.9/100 person-years (95% CI: 14.9–16.9) to 8.9/100 person-years (95% CI: 8.2–9.6), defined using only information recorded in the main diagnosis field, and from 25.5/100 person-years (95% CI: 24.4–26.8) to 19.4/100 person-years (95% CI: 18.5–20.4) using the main or secondary diagnoses respectively (Figure 1). In the same years, the incidence rate of all hospitalizations in Portugal decreased from 11.7/100 person-years (95% CI: 11.7–11.7) to 11.2/100 person-years (95% CI: 11.1–11.2) (Figure 1). The proportion of MS-related hospitalizations among all hospitalizations in Portugal decreased slightly from 0.07% to 0.05% between 2008 and 2013.

Table 1. Demographic and clinical characteristics of patients with MS hospitalized in 2008 and 2013.

MS as main diagnosisMS as main or secondary diagnosis
2008
(N=795)
2013
(N=576)
P value2008
(N=1277)
2013
(N=1264)
P value
Age of patients
hospitalized, years
   Mean39.140.50.03342.846.5<0.001
   SD11.912.313.414.6
Gender, n (%)
   Male264 (33.2)164 (28.5)0.062457 (35.8)387 (30.6)0.006
   Female531 (66.8)412 (71.5)820 (64.2)877 (69.4)
Length of stay (days)
   Median340.00644<0.001
   IQR1–61–61–72–8
Deaths during
hospitalization, n (%)
7 (0.9)2 (0.4)0.22739 (3.0)35 (2.8)0.669
Other diagnosis during
hospitalization, n (%)*
   Infectious and parasitic
diseases
3 (0.4)3 (0.5)0.69125 (2.0)22 (1.7)0.685
   Neoplasms7 (0.9)9 (1.6)0.24662 (4.9)74 (5.8)0.263
   Endocrine, nutritional and
metabolic diseases and
immunity disorders
93 (11.7)112 (19.4)<0.001188 (14.7)325 (25.7)<0.001
   Diseases of the blood and
blood-forming organs
21 (2.6)24 (4.2)0.11863 (4.9)122 (9.6)<0.001
   Mental disorders68 (8.6)130 (22.6)<0.001136 (10.6)277 (21.9)<0.001
   Diseases of the nervous
system and sense organs
(excluding MS)
347 (27.5)154 (26.7)<0.001202 (15.8)117 (14.7)<0.001
   Diseases of the circulatory
system
60 (7.6)106 (18.4)<0.001201 (15.7)370 (29.3)<0.001
   Diseases of the
respiratory system
24 (3.0)23 (4.0)0.328126 (9.9)180 (14.2)0.001
   Diseases of the digestive
system
11 (1.4)18 (3.1)0.02768 (5.3)139 (11.0)<0.001
   Diseases of the
genitourinary system
49 (6.2)48 (8.3)0.112179 (14.0)297 (23.5)<0.001
   Diseases of the skin and
subcutaneous tissue
10 (1.3)9 (1.6)0.63435 (2.7)72 (5.7)<0.001
   Diseases of the
musculoskeletal system and
connective tissue
20 (2.5)29 (5.0)0.01347 (3.7)90 (7.1)<0.001
   Congenital anomalies2 (0.2)0 (0.0)0.2284 (0.3)6 (0.5)0.516
   Symptoms, signs, and
ill-defined conditions
43 (5.4)118 (20.5)<0.00192 (7.2)233 (18.4)<0.001
   Injury and poisoning6 (0.8)7 (1.2)0.38558 (4.5)112 (8.9)<0.001

* Described according to the groups of diseases defined in the International Classification of Diseases 9th revision MS, multiple sclerosis; SD, standard deviation; IQR, interquartile range

a8be8c65-2a2e-4649-8193-f426191e9ff5_Figure1.gif

Figure 1. Incidence rate of MS-related and all hospitalizations in Portugal in 2008 and 2013.

The age of the patients with MS hospitalized and the length of stay in the hospital increased significantly (Table 1) between 2008 and 2013, where MS was either only a primary diagnosis or a diagnosis anywhere on the patient record. There was an increase in the proportions of females admitted to hospital but this was only significant when MS was recorded in any of the diagnosis fields (Table 1; p value = 0.062 for MS as main diagnosis and p value = 0.006 for MS as main or secondary diagnosis).

No differences were observed in the proportion of patients that died during hospitalization (Table 1). Where MS diagnosis was anywhere on the patient record, the proportion of MS patients with other diagnoses during hospitalization increased significantly between 2008 and 2013 for all groups of diseases considered, except for infectious and parasitic diseases, neoplasms, diseases of the nervous system and sense organs (excluding MS), and congenital anomalies (Table 1).

anoseq_numbersexoidaded1d2d3d4d5d6d7d8d9d10d11d12d13d14d15d16d17d18d19d20
200891404366815734040192724
2008914043674261340
2008914043680138340
2008914043686128340
2008914043974242340345907840
200891404440513275963621236217V4569340311
2008914080177253482934051881
2008914082802151V5869340
2008914108204240340
2008914108205240340
2008914108206240340
2008914108207240340
2008914108208240340
2008914108318239340
2008914109926228340
2008914110006249340
2008914110007249340
2008914110008249340
2008914110102229340
2008914110103229340
2008914110104229340
2008914110617147340
2008914110618147340
2008914110619147340
2008914111018132340
2008914111019132340
2008914111020132340
20089141119611545997340
200891411952215434059903441
2008914119816231340
2008914119839229V252340
200891412012224934078839599004185
2008914120172222340
20089141212321374151951884996645990340596543441
20089141225951424854853402761
2008914135439126340
2008914142903243340
2008914144581121340
20089141771722631623197019604592340250004019
2008914177987258340
200891418866523934078207804
20089141887192434905849340276534590
20089141950262510389402903405990574205862851574005720
20089142170992638202134099649V4364
20089142237711333403441781278133682V113
20089142243692394274125000340
2008914226601139V581340
2008914226741239V581340
200891422776125943140193403111370
20089142307572875990728893404273129410
200891423310822866001V27065221641116469134064631646112780166612648222851V1582
2008914233118239340
2008914233849151V5869340
20089142344702373407813272087340
2008914234894245V586934034417813
2008914248774238735473670340
2008914248953142592159205963340V4989
2008914249591220340
2008914249787249574103404019
2008914255555252340
2008914256700125340
200891425694625834056409
20089142582301478448340246927800
2008914260516253340
2008914261711245340340
2008914263334154340250024019
20089142635281308244340
20089142644162383405641443030043441
2008914264811228340340
2008914269191167599059900411134025000707032859
2008914270375229340
2008914270597238V252340
2008914273017242340
2008914278252237340
20089142786422572383340V643
2008914282544123340
2008914282802126340
2008914282902241340
2008914282910241340
2008914282911241340
2008914282921130340
2008914283240243340
2008914283367238340
2008914283560148340
2008914304828249482034590340345907807959900413
2008914306052128566340
2008914307915227340
200891430889625246605188134590340344897872
2008914309574242621314019340
20089143110512492182340
2008914312230139V581340
2008914312372239V581340
20089143134082374660340
20089143190061504865990340
2008914321247154482825180340
2008914323428248340
2008914367700130V71897820340V643
2008914367994138340780395990
200891436800625734059900416
2008914368018223340
20089143830912493405990788303110414
2008914384972143V6709340
200891438686826648642731340
200891450163014534036433441
2008914501641241340
20089145016422423403490
20089145019482543403117242
20089145024401327596V45693621236217340311
2008914505358256350134034610
2008914505475240335203403441
2008914505486233340
2008914507251233340
2008914508770222340
2008914510178151V5869340
2008914510772245V5869340
2008914510787232V5869340
20089145211222306489134059654V270
20089145250982363402669
20089145293392493404019
20089145300111233173017340
2008914530320154188259973404019
200891453032115418883404019
200891453046328451983401748V103V4500276512768
2008914531051235340
2008914534272149340
2008914534273149340
2008914536193154340250924019
200891453678813553410340
2008914537411240335203403441
200891453773013734048559905188427651344159654
200891453790325859907860978609401934550780393039342789340V1329V152V1272
2008914538369241340340
200891453906314259903404918
20089145472012605733340311
20089145499762426256340V252
2008914555385241340
2008914555388247340
200891455549325734040115990
2008914555518126340
2008914555799247340
2008914555888226340
2008914556284231340
2008914556439243340
2008914556471122340
2008914556561241340
2008914556594130340
2008914556717138340
2008914556762148340
2008914557157248340
2008914565806240340
20089145743402214704781947804779340
2008914574362258V5309340
200891457926814734032392724311266238910
200891457938224134031171535
20089145799421414140141114019340278004293305159202143V4582V5866
20089145804532453407883031130011
200891458049124119340192724340
20089145808952445965459654340
20089145808962445965459654340V643
200891458151714219183402429030513047334290
2008914583798160599027651584929040340
2008914585468239V581340
2008914585584139V581340
20089145866402243403410
20089145874971544660599004185340
200891459505713846605188434057420
2008914596387223340
2008914599773248340
2008914604900124340
20089146074322629245891045981V5861403903403659
2008914608781137340
2008914608950130340
20089146101322582387340V1259728887806
2008914610747238340
2008914723909254340
20089147245352373402720
2008914724658248340V1271V1279
2008914725828259518842780140192449340
2008914726787245V5869340
2008914726804232V5869340311
2008914727394130V5869340
200891472744314741041401925000272434041401
20089147275902762930793040112768340276578703
2008914727697151V5869340
2008914727824231V5869340
2008914729166233340
2008914729846235340
2008914735707225340
2008914739567239717271783340
200891474033415418883404019
2008914745245149340
20089147455461243869340
2008914745916139340
2008914747107238340340
2008914748464155340
2008914748988141340
20089147502231293403441
200891475049224934059654
20089147506121375990599034034415969
This is a portion of the data; to view all the data, please download the file.
Dataset 1.Data of multiple sclerosis related hospitalizations in Portugal.
The raw data of incidence rate of multiple sclerosis related hospitalization between 2008 and 2013 are reported.

Discussion

Here we show a decrease in MS-related hospitalizations in Portugal from 2008 to 2013. Where MS was the primary diagnosis the decrease was substantial — approximately 44%. The rates of hospitalization observed in Portugal appear to be similar to that documented in Canada2,3, suggesting perhaps that the thresholds for admission are similar between the two countries. The change in hospitalization rates cannot be explained entirely by a general change in admissions in Portugal, although this did decline by 4%. The change in hospitalization coincides with the release of new therapies for MS, the first of which, natalizumab (Tysabri®), became available in June 2007 in Portugal7. It is plausible that these newer therapies prevented some hospital admissions for patients with MS. The average age of MS patients admitted in 2013 was older as compared to 2008. As MS prevalence has increased over the period, the decrease in hospitalization rate may reflect a diluting by more newly diagnosed patients with lower disease severity. There may also be a change in the way healthcare is delivered, with a possible shift to more outpatient services as seen in other countries. This may explain why the average length of stay for MS-related admissions has increased while the rate of admissions has decreased, although this change in disease management has generally preceded the time period we have investigated in other countries.

Limitations of this study include the lack of clinical data and information on potential confounders. There are also the uncertainties associated with the prevalence data we had available to us. Despite these limitations, our results are in accordance with previous results on hospital admissions in patients with MS. Our findings provide further epidemiological data on MS in Portugal, healthcare resource use in these patients, and impetus to investigate other efforts to reduce hospitalizations in this population.

Data availability

The Portuguese Central Administration of the Health System provided the database and gave permission to use the data to describe in the article. The data are not available online, but are available upon request after approval of the study objectives.

F1000Research: Dataset 1. Data of multiple sclerosis related hospitalizations in Portugal, http://dx.doi.org/10.5256/f1000research.8787.d1255898

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 13 Jun 2016
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Pereira M, Lambrelli D and Ramagopalan SV. Decrease in rate of multiple sclerosis-related hospitalizations in Portugal [version 1; peer review: 2 approved]. F1000Research 2016, 5:1353 (https://doi.org/10.12688/f1000research.8787.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 13 Jun 2016
Views
8
Cite
Reviewer Report 06 Jul 2016
Bruce V Taylor, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia 
Approved
VIEWS 8
This is an interesting short report that documents a significant fall in the number of hospitalisations for MS in Portugal following the release of higher potency disease modifying drugs. The observation is interesting and adds some support to the presumed ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Taylor BV. Reviewer Report For: Decrease in rate of multiple sclerosis-related hospitalizations in Portugal [version 1; peer review: 2 approved]. F1000Research 2016, 5:1353 (https://doi.org/10.5256/f1000research.9457.r14810)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
11
Cite
Reviewer Report 21 Jun 2016
João Correia de Sa, Department of Neurosciences and Mental Health, Neurology Department, Santa Maria Hospital, Lisbon, Portugal 
Approved
VIEWS 11
The paper by Pereira and co-workers addresses an relevant issue: to bring to public some data about the hospitalization rates of MS patients in Portugal.

There are no methodological errors but, in my opinion, some changes should ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
de Sa JC. Reviewer Report For: Decrease in rate of multiple sclerosis-related hospitalizations in Portugal [version 1; peer review: 2 approved]. F1000Research 2016, 5:1353 (https://doi.org/10.5256/f1000research.9457.r14457)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 13 Jun 2016
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.